Brief: Tonix Pharmaceuticals Secures Second Commercial Payer Agreement For Tonmya®, Expanding Total Commercial Coverage To ~52 Million U.S. Lives
08/06/2026 12:10
BRIEF-Tonix Pharmaceuticals Secures Second Commercial Payer Agreement For Tonmya®, Expanding Total Commercial Coverage To ~52 Million U.S. Lives June 8 (Reuters) - Tonix Pharmaceuticals Holding Corp TNXP.O:
TONIX PHARMACEUTICALS SECURES SECOND COMMERCIAL PAYER AGREEMENT FOR TONMYA®, EXPANDING TOTAL COMMERCIAL COVERAGE TO ~52 MILLION U.S. LIVES
Source text: ID:nGNX7xpt80
Further company coverage: TNXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tonix Pharmaceuticals Holding
See all newsBrief: Tonix Pharmaceuticals Secures Second Commercial Payer Agreement For Tonmya®, Expanding Total Commercial Coverage To ~52 Million U.S. Lives
Tonix Pharmaceuticals Q1 net loss widens on higher SG&A expenses
Brief: Tonix Pharmaceuticals Announces Presentations At World Vaccine Congress Washington 2026
Tonix Pharmaceuticals Q4 revenue more than doubles, net loss widens
Brief: Tonix Pharmaceuticals Announces Uplisting From Nasdaq Capital Market To Nasdaq Global Select Market